Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4185 - 4192 of 11613 results
Coronavirus Forces Employers to Act with Caution in Workplace
January 30, 2020| News
Congressional Privacy Action – Part 2: The House
January 29, 2020| Blog| Viewpoint
Health Plan Transparency Rule: Comment Period Ends This Week
January 29, 2020| Blog| Viewpoint
Pre-Closing Covenants: Operating in the Ordinary Course of Business
January 29, 2020| Article| Viewpoint
FCA's Epic Run In 2010s Will Be Hard To Match In 2020s
January 29, 2020| News
Public Charge Order Sparks Confusion For Immigration Attys
January 29, 2020| News
Coronavirus Outbreak Causes Employers to Consider Precautionary Steps
January 28, 2020| Blog| Viewpoint
FDA User Fees: How Do They Work?
January 28, 2020| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.